Topographic correspondence of macular atrophy with choroidal neovascularization in ranibizumab treated eyes of the TREX-AMD trial
American Journal of Ophthalmology May 18, 2018
Abdelfattah NS, et al. - Experts ascertained the extent of topographic correspondence between baseline (BSL) choroidal neovascularization (CNV) and macular atrophy (MA) at follow-up in eyes with neovascular age-related macular degeneration (NVAMD). Results demonstrated the development of more MA lesions within the region of baseline-CNV (Type-I, CNV-based MA) than outside (Type-II, CNV-independent MA) in ranibizumab-treated eyes with NVAMD. In the pre-treatment phase, baseline-MA also tended to be located within regions of CNV.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries